Fierce Biotech News & Reports Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us Biotech Cell & Gene Therapy Clinical Data Venture Capital Deals Research Medtech Devices Diagnostics AI and Machine Learning CRO Special Reports Fierce 50 Special Report Awards Gala Resources Fierce Events Industry Events Webinars Podcasts Whitepapers Survey Events Subscribe Subscribe Biotech Cell & Gene Therapy Clinical Data Venture Capital Deals Research Medtech Devices Diagnostics AI and Machine Learning CRO Special Reports Fierce 50 Special Report Awards Gala Resources Fierce Events Industry Events Webinars Podcasts Whitepapers Survey Events Subscribe Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us Biotech Roche, Alnylam celebrate second ph. 2 win for blood pressure med In further proof that Roche’s $310 million bet will pay off, the Big Pharma’s Alnylam-partnered hypertension drug has notched another win. James Waldron Mar 5, 2024 9:05am Sponsored How CDMO Wacker Biotech is inspiring innovation in mRNA therapeutics Mar 4, 2024 8:00am VC investment in biopharma dropped nearly $7B in 2023: PitchBook Mar 5, 2024 5:00am Sponsored A new chapter for biotech: Confidence returns to the market Mar 4, 2024 8:00am Catawba names Syed Faridi VP of global business development Mar 4, 2024 4:50pm Sponsored NYC's Bold Move: Life Sciences Take Center Stage Mar 4, 2024 8:00am Medtech News Medtronic gets FDA OK for upgraded bone tumor ablation system Mar 4, 2024 11:00am Baxter weighs sale vs. spinout for Vantive kidney care division Mar 4, 2024 10:46am Fierce Medtech's Fierce 15 of 2023 Mar 4, 2024 3:00am Bos Sci nets first US approval for drug-coated coronary balloon Mar 1, 2024 1:49pm See More Medtech News Connect The Team Advertise Join Us Newsletters Resources RSS Feeds Our Brands Fierce Pharma Fierce Biotech Fierce Healthcare Our Events Life Sciences Events ©2024 Questex LLC All rights reserved. Terms of use Privacy Policy Privacy Settings